Valneva (VALN) news
Recent news
Valneva SE shares up 12% to top of SBF 120 index after EMA validates Pfizer and Valneva's Lyme disease vaccine application
AInvest Wire · Aug 14, 2026Pfizer, Valneva Lyme vaccine MAA validated by EMA
AInvest Wire · Aug 14, 2026Valneva SE shares fall 6.5% after H1 results
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) reported its first-half 2026 consolidated financial results on August 13, 2026, following which its shares declined by 6.5% . The company hosted a live webcast to discuss the results and provide a business update, accessible on its website. The stock…
AInvest Wire · Aug 13, 2026Valneva 1H operating loss EUR49.9M vs. loss EUR16.8M y/y
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) reported an operating loss of €49.9 million for the first half of 2025, compared to a loss of €16.8 million in the same period of the prior year, according to its half-year financial results. The increase in the operating loss reflects ongoing R&D…
AInvest Wire · Aug 13, 2026Valneva SE - Anne-Marie Graffin will continue as vice-chair of board
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) announced on December 20, 2023, that its shareholders approved the transition from a two-tier governance model to a one-tier model led by a Board of Directors. As part of this restructuring, Anne-Marie Graffin, a former Supervisory Board member, was…
AInvest Wire · Jun 25, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.